P
US7723089B2ExpiredUtilityPatentIndex 95

PEG-urate oxidase conjugates and use thereof

Assignee: MOUNTAIN VIEW PHARMACEUTICALSPriority: Aug 6, 1998Filed: Apr 19, 2001Granted: May 25, 2010
Est. expiryAug 6, 2018(expired)· nominal 20-yr term from priority
Inventors:WILLIAMS L DAVIDHERSHFIELD MICHAEL SKELLY SUSAN JSAIFER MARK G PSHERMAN MERRY R
A61P 3/00C12N 9/0048C12N 9/0046C12N 9/96A61P 13/12C12Y 107/03003A61P 19/06A61K 38/00C12N 9/0093A61K 47/60
95
PatentIndex Score
33
Cited by
105
References
8
Claims

Abstract

A naturally occurring or recombinant urate oxidase (uricase) covalently coupled to poly(ethylene glycol) or poly(ethylene oxide) (both referred to as PEG), wherein an average of 2 to 10 strands of PEG are conjugated to each uricase subunit and the PEG has an average molecular weight between about 5 kDa and 100 kDa. The resulting PEG-uricase conjugates are substantially non-immunogenic and retain at least 75% of the uricolytic activity of the unmodified enzyme.

Claims

exact text as granted — not AI-modified
1. An isolated recombinant tetrameric mammalian uricase, wherein said uricase is in a substantially tetrameric form, wherein less than 10% of said uricase is in a non-tetrameric aggregated form, and wherein said uricase is chimeric. 
     
     
       2. The isolated tetrameric uricase of  claim 1 , wherein said chimeric uricase contains portions of porcine liver and baboon liver uricases. 
     
     
       3. The isolated tetrameric uricase of  claim 2 , wherein said chimeric uricase is pig-baboon chimeric uricease. 
     
     
       4. An isolated recombinant tetrameric mammalian uricase, wherein said uricase is recombinant porcine uricase containing lysine in place of arginine at residue number 291 in SEQ ID NO:1 and serine in place of threonine at residue number 301 in SEQ ID NO:1. 
     
     
       5. An isolated recombinant tetrameric mammalian uricase, wherein said uricase has the sequence of baboon liver uricase in which tyrosine 97 in SEQ ID NO:2 has been replaced by histidine. 
     
     
       6. The isolated tetrameric uricase of  claim 1 , wherein said uricase comprises an amino terminus and a carboxyl terminus, and wherein the uricase is truncated at one terminus or both termini. 
     
     
       7. The isolated tetrameric uricase of  claim 4 , wherein said uricase comprises an amino terminus and a carboxyl terminus, and wherein the uricase is truncated at one terminus or both termini. 
     
     
       8. The isolated tetrameric uricase of  claim 5  wherein said uricase comprises an amino terminus and a carboxyl terminus, and wherein the uricase is truncated at one terminus or both termini.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.